|
|
|
Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries
Room1404,No.2025 ZhongShanXi Road,YunSun Tower
Shanghai 200235
China
Phone: +86-21-64396936
Fax: +86-21-64814386
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Oripharm is one professional biochemicals manufacturer and supplier in China.Since its establishment in 2003,Oripharm grows rapidly in the field of Nucleic Acid biochemistry. We develop and commercialization many kinds of active substances, key intermediates And reagents which are being widely used in pharmaceuticals, diagnostics, cosmetics, Molecular biology and food industry as well. Oripharm are concentrated on Nucleosides,Nucleotides and their analogues. We offer more than 250 products including various kinds of Ribonucleosides, Ribonucleotides,Deoxynucleosides, Deoxynucleotides, Arabinonucleosides,Carbohydrates,CoenzymesCyclophosphaets,Purines and Pyrimidines.All the products have been applied in theWorldwide pharmaceutical company,biotechnology company, diagnostics company,Cosmetics company and foodstuff company. Due to reliable quality products and excellent services,Oripharm enjoy a good popularity among our global customers in the past years and also establish a important collaboration relations with several famous multinational companies in the world. Oripharm’s main strength is not only to supply high quality products to our customers But also continuously develop advanced technology and special items to meet our customers continuous growing special requirements. We would like always stand at forehead of Nucleic Acid Biochemistry and win with our customer in the future. Oripharm would like dedicate ourselves to human life science industry.
Selected Categories:
Last update of this entry: October 28, 2016
|